Press "Enter" to skip to content

New patent expiration for Astrazeneca Ab drug SYMLIN

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Astrazeneca Ab drug SYMLIN

Annual Drug Patent Expirations for SYMLIN
Annual Drug Patent Expirations for SYMLIN

Symlin is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.

This drug has thirty-one patent family members in sixteen countries.

The generic ingredient in SYMLIN is pramlintide acetate. One supplier is listed for this compound. Additional details are available on the pramlintide acetate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent expiration for Astrazeneca Ab drug SYMLIN
    Do NOT follow this link or you will be banned from the site!